亚虹医药获得发明专利授权：“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”

证券之星企业动态2025-07-15

证券之星消息，根据天眼查APP数据显示亚虹医药（688176）新获得一项发明专利授权，专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”，专利申请号为CN201780032148.5，授权日为2025年7月15日。专利摘要：描述了包括硝羟喹啉、其类似物或其药学上可接受的盐与至少一种额外的抗癌化学治疗剂或免疫治疗剂的新型组合疗法。还描述了相关试剂盒、药物组合物或其生产方法。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551913364?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-15 02:38","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551913364","market":"sh","top_or_hot":-1,"title":"亚虹医药获得发明专利授权：“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”","media":"证券之星企业动态","content":"<div>\n<p>证券之星消息，根据天眼查APP数据显示亚虹医药（688176）新获得一项发明专利授权，专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”，专利申请号为CN201780032148.5，授权日为2025年7月15日。专利摘要：描述了包括硝羟喹啉、其类似物或其药学上可接受的盐与至少一种额外的抗癌化学治疗剂或免疫治疗剂的新型组合疗法。还描述了相关试剂盒、药物组合物或其生产方法。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亚虹医药获得发明专利授权：“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亚虹医药获得发明专利授权：“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-15 02:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b><strong>证券之星企业动态</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，根据天眼查APP数据显示亚虹医药（688176）新获得一项发明专利授权，专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”，专利申请号为CN201780032148.5，授权日为2025年7月15日。专利摘要：描述了包括硝羟喹啉、其类似物或其药学上可接受的盐与至少一种额外的抗癌化学治疗剂或免疫治疗剂的新型组合疗法。还描述了相关试剂盒、药物组合物或其生产方法。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b","article_id":"2551913364","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551913364","pubTimestamp":1752518296,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"证券之星消息，根据天眼查APP数据显示亚虹医药新获得一项发明专利授权，专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”，专利申请号为CN201780032148.5，授权日为2025年7月15日。今年以来亚虹医药新获得专利授权1个，与去年同期持平。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688176":"亚虹医药-U","BK0239":"医药制造"},"translate_title":"Yahong Pharmaceutical obtained invention patent authorization: \"Combined use of nitroquinoline and its analogs with chemotherapy and immunotherapy in cancer treatment\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688176":1},"content_text":"证券之星消息，根据天眼查APP数据显示亚虹医药（688176）新获得一项发明专利授权，专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”，专利申请号为CN201780032148.5，授权日为2025年7月15日。专利摘要：描述了包括硝羟喹啉、其类似物或其药学上可接受的盐与至少一种额外的抗癌化学治疗剂或免疫治疗剂的新型组合疗法。还描述了相关试剂盒、药物组合物或其生产方法。今年以来亚虹医药新获得专利授权1个，与去年同期持平。结合公司2024年年报财务数据，2024年公司在研发方面投入了3.12亿元，同比减14.45%。通过天眼查大数据分析，江苏亚虹医药科技股份有限公司共对外投资了3家企业，参与招投标项目2次；财产线索方面有商标信息123条，专利信息50条，著作权信息8条；此外企业还拥有行政许可18个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551913364","isCrawlerRequest":true}